THE NHS AT 60 AND THE LORD DARZI REVIEW
Presentations From Recent Heart Rhythm Society Meeting Validate ...
PR Newswire (press release) - New York,NY,USA
ATHENA Clinical Results With Dronedarone (Multaq(R)) Highlighted ...
ATHENA Clinical Results for Dronedarone (Multaq(R)) Highlighted at ...
HRS: Electrophysiologists Must Work to Restore Trust After Recalls
Medtronic Has A Heart
Forbes - NY,USA
Two UW-Madison researchers receive Shaw Awards
Innovative research that could help develop drugs to treat disorders such as epilepsy and cardiac arrhythmias, and a novel approach to advancing the ...
See all stories on this topic
HRS: Pacemakers Don't Prevent Arrhythmia in Mild Heart Failure
HRS: Investigational Atrial Fibrillation Agent Wins High Marks in ...
HRS: Statins Linked to Lower Atrial Fibrillation Risk in Women
MedPage Today - Little Falls,NJ,USA
St. Jude says its wires have low problem rate
Minneapolis Star Tribune - Minneapolis,MN,USA
Rapid Growth in Cardiovascular Implant Devices Spurs New ...
SeniorJournal.com - San Antonio,TX,USA
HRS: Remote Monitoring of ICDs Helps Clinicians Cope with Patient ...
MedPage Today - Little Falls,NJ,USA
Medtronic defibrillators win FDA approval
MSN Money - USA
Medtronic Inc. said it won FDA approval Tuesday on a new line of wireless cardiac defibrillators. Fridley-based device maker Medtronic (NYSE: MDT) said its ...
See all stories on this topic
The American College of Cardiology, American Heart Association and ...
Earthtimes (press release) - London,UK
First European implant of new pacemaker
Hospital Healthcare Europe - London,England,UK
Medtronic Announces FDA Approval of New Vision 3D Wireless ...
PR-Inside.com (Pressemitteilung) - Wien,Austria
Cardiac nurses praised
Daily Post - Llandudno Junction,UK
Medtronic to cut back on R&D at local unit
Pioneer Press - St. Paul,MN,USA
ICD lead revision needed in few patients
Implantable cardioverter defibrillator lead malfunction requiring surgical revision occurs in just 2.5% of patients over 5 years, reports a European team of cardiologists.
Circulation 2008; 117: 2727-2733
Acute infarct size better predicts STEMI outcomes than LV systolic function
Acute infarct size measured by cardiac magnetic resonance imaging after ST-elevation myocardial infarction is a better predictor of outcomes than measures of left ventricular systolic function, research suggests.
Heart 2008; 94: 730-736
Heart Device Recipients Often Not Aware of Recalls
New Guidelines Issued for Implanted Heart Devices
Statins May Help Older Women Control Irregular Heartbeat
Stroke Patients at High Risk for Falls
The Medical Technology Group - Weber Shandwick:
Written Answer: Cardiovascular System: Screening
The Guardian: NHS reforms rule out closure of hospitals before election
The Guardian: The NHS, but not as you know it
Financial Times: Hospitals to be paid based on performance
The Guardian: Our proposals are about improving the NHS, not privatising it
PharmaTimes: Draft Queen's Speech reveals Government NHS reform plans
Study rules out aprotinin in high-risk cardiac surgery
The consistently increased risk for mortality associated with aprotinin compared with lysine analogues precludes its use in patients undergoing high-risk cardiac surgery, say the BART investigators.
N Engl J Med 2008; Advance online publication
Cardiac troponin predicts mortality in acute decompensated heart failure
Cardiac troponin elevation is associated with increased in-hospital mortality in patients with acute decompensated heart failure, research reveals.
N Engl J Med 2008; 358 : 2117-2126
Combination of multiple biomarkers predicts cardiovascular death risk
The use of multiple biomarkers of renal and cardiovascular abnormalities improves the risk stratification of patients for death from cardiovascular disease, researchers suggest.
N Engl J Med 2008; 358 : 2107-2116.
Prevention
HEARTWIRE NEWS:
Electrophysiology
Dronedarone safety, efficacy standings bolstered in huge atrial-fibrillation trial
Envisioned as a safer alternative to amiodarone for maintaining sinus rhythm, dronedarone seemed to cut the risk of CV hospitalization or death in the randomized ATHENA trial's very elderly, "moderate- to high-risk" population. (Heart Rhythm Society 2008 Scientific Sessions.) [19 May]
Antiarrhythmics safely suppress atrial arrhythmias after AF ablation in randomized trial
Such therapy is common but not consistently performed, and the risks aren't well defined, researchers observe. The strategy they used seems to seems to work without serious complications, at least in the short term. (Heart Rhythm Society 2008 Scientific Sessions.) [17 May]
Remote pacemaker follow-up: Interrogation by internet likely superior to "over-the-phone" ECG
Hopes are that having remote access to all the data modern devices collect will ultimately improve clinical outcomes, but for now, a randomized trial shows that remote pacemaker interrogations catch more events than standard transtelephonic monitoring. (Heart Rhythm Society 2008 Scientific Sessions.) [16 May]
Implantable device "recall" vs "safety advisory": The power of the R word
Using the latter term might cause slightly fewer patients to insist on device change-outs and therefore fewer change-out-related complications, according to researchers. (Heart Rhythm Society 2008 Scientific Sessions.) [15 May]
Costs of heavy drinking:
Arterial stiffness, hypertension for men, and enlarged hearts for women
Remote Pacemaker Follow-Up:
Interrogation by Internet Likely Superior to "Over-the-Phone" ECG
Heartwire
Implantable Device "Recall" vs "Safety Advisory": The Power of the R Word
Heartwire
|